1994
DOI: 10.1016/0014-2999(94)90788-9
|View full text |Cite
|
Sign up to set email alerts
|

Autonomic modulation of action potential and tension in guinea pig papillary muscles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1999
1999
2014
2014

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…Among five muscarinic receptor subtypes (Brodde and Michel, 1999), M1, M2, and M3 are present in the heart (Brodde and Michel, 1999;Fisher et al, 2004;Wang et al, 2007), with the M2 receptor having a dominant chronotropic effect (Fisher et al, 2004). The endogenous muscarinic receptor agonist acetylcholine (ACh) has been reported to shorten the QT interval on an electrocardiogram (ECG) (Patel et al, 2010), and stimulation of muscarinic receptors with carbachol (CCh) reduces the ventricular action potential duration (APD) in papillary muscles (Arreola et al, 1994). Recently, it was reported that M3 muscarinic receptor overexpression reduces the incidence of arrhythmias and mortality associated with myocardial ischemia/reperfusion in mice (Liu et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Among five muscarinic receptor subtypes (Brodde and Michel, 1999), M1, M2, and M3 are present in the heart (Brodde and Michel, 1999;Fisher et al, 2004;Wang et al, 2007), with the M2 receptor having a dominant chronotropic effect (Fisher et al, 2004). The endogenous muscarinic receptor agonist acetylcholine (ACh) has been reported to shorten the QT interval on an electrocardiogram (ECG) (Patel et al, 2010), and stimulation of muscarinic receptors with carbachol (CCh) reduces the ventricular action potential duration (APD) in papillary muscles (Arreola et al, 1994). Recently, it was reported that M3 muscarinic receptor overexpression reduces the incidence of arrhythmias and mortality associated with myocardial ischemia/reperfusion in mice (Liu et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Zhang et al (1998) showed that ACh decreased the contractile force of guinea‐pig atria in a dose‐dependent manner, whereas there was no effect on contractile function of the ventricular trabeculae. Stimulation of muscarinic ACh receptors with carbachol reduces the APD and has a positive inotropic effect in papillary muscles from both ventricles, with both effects being concentration dependent and atropine sensitive (Arreola et al 1994); ACh applied at 0.03–0.3 μ m to isolated guinea‐pig ventricular papillary muscle resulted in a significant shortening of APD and the contractile force showed no change or only a slight decrease, while ACh applied at 5 μ m reduced APD 50 and APD 90 whilst the contractile force was slightly increased (Yang et al 1989); in the presence of 10 μ m physostigmine (a cholinesterase inhibitor), ACh produced concentration‐dependent negative and positive inotropic effects in the presence and absence of the phosphodiesterase inhibitor IBMX (3‐isobutyl‐1‐methyl xanthine, 100 μ m ), with half‐maximal effective concentrations of 1.36 and 46 μ m , respectively (Korth et al 1987). The above‐mentioned studies did not compare the effects on the atria and the ventricles systemically, and the results are controversial.…”
Section: Discussionmentioning
confidence: 99%
“…The review article by Casadei (2001) provided evidence for a vagal/muscarinic regulation of left ventricular function in humans. In guinea‐pig ventricles, the available data on the direct negative effect of muscarinic agonists are not consistent (Korth & Kuhlkamp, 1987; Yang et al 1989; Arreola et al 1994; Zhang et al 1998). Moreover, the comparative effect of ACh on atrial and ventricular myocytes and the relationship between the force of contraction and the duration of the action potential are still unclear.…”
mentioning
confidence: 99%